Results 21 to 30 of about 459,568 (307)

La empatía médica, ¿nace o se hace? Evolución de la empatía en estudiantes de medicina

Atención Primaria, 2016
Introducción y objetivos: La empatía es una de las competencias básicas en el aprendizaje de la medicina, relacionándose con mejor relación médico-paciente, mejor competencia profesional y menor estrés profesional.
Montse Esquerda, Oriol Yuguero, Joan Viñas, Josep Pifarré   +3 more
doaj   +1 more source

Integrating and formatting biomedical data as pre-calculated knowledge graph embeddings in the Bioteque

Nature Communications, 2022
Biomedical data is accumulating at a fast pace and integrating it into a unified framework is a major challenge. Here, the authors present a resource that contains pre-calculated biomedical descriptors derived from a very large knowledge graph.
Adrià Fernández-Torras, Miquel Duran-Frigola, Martino Bertoni, Martina Locatelli, Patrick Aloy   +4 more
doaj   +1 more source

What Is an IRB, Why Do We Need It, and What Is a Private IRB?

, 2010
Many foot and ankle specialists have interest in publishing research or technique articles to share their expertise with colleagues. It is now commonplace for medical journals to require all studies that involve patients or patient data to have ...
Hyer, Christopher F
core   +1 more source

Microtubule nucleation and γTuRC centrosome localization in interphase cells require ch-TOG

Nature Communications, 2023
The molecular mechanisms underpinning the organization of microtubule arrays remain unclear. Here the authors show that in human cells, the microtubule polymerase ch-TOG promotes nucleation of microtubules at the interphase centrosome and the Golgi ...
Aamir Ali, Chithran Vineethakumari, Cristina Lacasa, Jens Lüders   +3 more
doaj   +1 more source

IRB Accreditation and Local IRB Operations

, 2009
As presented at IASSIST 2009 ...
Elizabeth Stephenson, Jacob Carlson, Thomas Lindsay   +2 more
openaire   +3 more sources

How local IRBs view central IRBs in the US [PDF]

BMC Medical Ethics, 2011
Background: Centralization of IRB reviews have been increasing in the US and elsewhere, but many questions about it remain. In the US, a few centralized IRBs (CIRBs) have been established, but how they do and could operate remain unclear. Methods: I contacted 60 IRBs (every fourth one in the list of the top 240 institutions by NIH funding), and ...
openaire   +4 more sources

Clinical and Biological Features of Response in Resistant Neuroblastoma to 131I‐Metaiodobenzylguanidine Radiotherapy in the Anti‐GD2 Immunotherapy Era

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background 131I‐metaiodobenzylguanidine (131I‐MIBG) radiotherapy is a key treatment for relapsed and refractory (R/R) neuroblastoma (NB). Patients with R/R disease treated in the modern era are increasingly exposed to anti‐GD2 immunotherapy, which exerts selective pressure and may modify both tumor cell state and microenvironment.
Benjamin J. Lerman, Katherine K. Matthay, Fabienne Hollinger, Catriona Black, Ann A. Lazar, Miguel Pampaloni, Steven G. DuBois, Kieuhoa T. Vo   +7 more
wiley   +1 more source

Venous Thromboembolism in Pediatric Bone Sarcoma Patients: A 10‐Year, Single‐Institution Experience Encompassing the COVID‐19 Pandemic

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Osteosarcoma (OS) and Ewing sarcoma (EWS) are the most common primary bone cancers in children, but acute thrombosis is poorly characterized in this population. Our study evaluated the rates of venous thromboembolism (VTE) and associated risk factors in pediatric patients with bone sarcomas treated over a 10‐year period encompassing
Sarah Kappa, Shou Xu, Mark Zobeck, Sarah E. Sartain, Nino Rainusso, Lisa Wang, Nicole Montgomery, Paige Wheaton, Sarah Whittle   +8 more
wiley   +1 more source

IRB Approval

, 2016
This contains the IRB information used for the study.
Delora Everett, Dana C. Leighton
core   +3 more sources

Time Toxicity in Wilms Tumor: Quantifying the Burden of Healthcare Interaction in the First Year After Diagnosis

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Wilms tumor (WT) treatment imposes a significant time burden on patients and their families. Time toxicity is a patient‐centered metric that quantifies the burden of healthcare interaction. We sought to define time toxicity in the first year after diagnosis of WT and hypothesized that it would increase as tumor stage and treatment ...
Caleb Q. Ashbrook, Veerain Gupta, Nicholas J. Clark, Vijay Rings, Lauren E. Corona, Douglass B. Clayton, Daniel J. Benedetti   +6 more
wiley   +1 more source